Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ACTRN12626000141347) titled 'Critical Illness, Infection and Immunology Biobank' on Feb. 4.
Study Type: Observational
Study Design:
Purpose: Screening
Duration: Longitudinal
Timing: Prospective
Primary Sponsor: NSW Health
Condition:
Sepsis
Critical Illness
Sepsis
Critical Illness
Inflammatory and Immune System - Other inflammatory or immune system disorders
Infection - Studies of infection and infectious agents
Intervention:
CI3 Biobank is an open biospecimen repository (biobank) created to facilitate future translational research into conditions such as sepsis, including but not limited to cellular, molecular, transcriptomic, pro...